Repertoire Immune Medicines Welcomes Dr. Robert Andtbacka as New Chief Medical Officer Repertoire Immune Medicines appoints Dr. Robert Andtbacka as CMO, enhancing leadership as they advance a promising TCR bispecific therapy into clinical trials.

Repertoire Immune Medicines Welcomes Dr. Robert Andtbacka as New Chief Medical Officer #United_States #Cambridge #Repertoire_Immune #Robert_Andtbacka #TCR_Bispecific